THE EFFECT OF AN ORAL NASAL DECONGESTANT UPON THE MENSTRUAL CYCLE.
D002744:Chlorpheniramine; D004714:Endometrial Hyperplasia; D004715:Endometriosis; D005260:Female; D006634:Histamine H1 Antagonists; D006801:Humans; D007246:Infertility; D007247:Infertility, Female; D007889:Leiomyoma; D008598:Menstruation; D008599:Menstruation Disturbances; D014663:Nasal Decongestants; D010276:Parasympatholytics; D010600:Pharmacology; D010665:Phenylpropanolamine; D000644:Quaternary Ammonium Compounds; D013566:Sympathomimetics
D006634:Histamine H1 Antagonists; D014663:Nasal Decongestants; D010276:Parasympatholytics; D000644:Quaternary Ammonium Compounds; D013566:Sympathomimetics; D010665:Phenylpropanolamine; D002744:Chlorpheniramine; C084831:isopropamide iodide
ANTIHISTAMINICS; CHLORPHENIRAMINE; ENDOMETRIAL HYPERPLASIA; ENDOMETRIOSIS; ISOPROPAMIDE IODIDE; LEIOMYOMA; MENSTRUATION; MENSTRUATION DISORDERS; PARASYMPATHOLYTICS; PHARMACOLOGY; PHENYLPROPANOLAMINE; STERILITY, FEMALE; SYMPATHOMIMETICS